ecubectedin
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 6, 2017 (NCT05076396)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- DNAINHIBITOR
DNA inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05146440 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2021 | Grupo Espanol de Investigacion en Sarcomas, Universidad Autonoma de Barcelona, Universidad Autonoma de Madrid, University of Barcelona, University of Zaragoza |
| NCT05076396 | Phase 1 | Sep 6, 2017 | PharmaMar |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Grupo Espanol de Investigacion en Sarcomas | Academic/Hospital | 1 | 1 | 1 | 2021 |
| PharmaMar | For profit | 1 | 1 | 1 | 2017 |
| Universidad Autonoma de Barcelona | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Universidad Autonoma de Madrid | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Barcelona | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Zaragoza | Academic/Hospital | 1 | 0 | 1 | 2021 |
6 organizations
Page 1 / 1